Approval · Notice of Compliance 732 · 2002
DITROPAN: Notice of Compliance 732
Issued February 21, 2002
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 732
- Date
- February 21, 2002
- Company
- Janssen-Ortho Inc.
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Manufacturer name change
- Therapeutic class
- Anticholinergic/antispasmodic agent
Products in this notice
Medicinal ingredients
- OXYBUTYNIN CHLORIDE 5 MG per TAB
- OXYBUTYNIN CHLORIDE 1 MG per ML